Daiichi Life subsidiary makes conditional A$11.80 a share approach for Challenger, sparking takeover debate on ASX
Challenger Limited said on 19 October 2026 it has received a non binding, conditional indicative proposal from TAL Daiichi Life Australia to buy the 79.5 percent it does not already own at A$11.80 per share. The approach values the retirement and annuities specialist at roughly A$7.9 billion and lifts takeover activity across the ASX.